AMANDA GOLDEN: Open Payments
NPI 1578214763 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,216 in 131 payments from 26 companies in 2025. Trend: 2023 $1,885 · 2024 $1,790 · 2025 $2,216
Food & beverage: $2,216
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 47 | $525 |
| Lundbeck LLC | 8 | $257 |
| Lilly USA, LLC | 13 | $214 |
| Eisai Inc. | 5 | $156 |
| PFIZER INC. | 19 | $153 |
| EMD Serono, Inc. | 6 | $144 |
| Teva Pharmaceuticals USA, Inc. | 4 | $79 |
| Novartis Pharmaceuticals Corporation | 3 | $77 |
| Alnylam Pharmaceuticals Inc. | 3 | $74 |
| SpringWorks Therapeutics, Inc. | 3 | $57 |
Products named: QULIPTA, VYEPTI, Leqembi, KISUNLA, NURTEC ODT, AUSTEDO XR, KESIMPTA, AMVUTTRA.
Industry payments across MD — which companies pay providers there.
